CN113631923A - 辅助肾病况的评价的方法、肾病况的评价系统及肾病况的评价程序 - Google Patents

辅助肾病况的评价的方法、肾病况的评价系统及肾病况的评价程序 Download PDF

Info

Publication number
CN113631923A
CN113631923A CN202080022905.2A CN202080022905A CN113631923A CN 113631923 A CN113631923 A CN 113631923A CN 202080022905 A CN202080022905 A CN 202080022905A CN 113631923 A CN113631923 A CN 113631923A
Authority
CN
China
Prior art keywords
serine
asparagine
amount
excretion rate
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080022905.2A
Other languages
English (en)
Chinese (zh)
Inventor
三田真史
池田达彦
木村友则
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mirror Co ltd
National Institutes of Biomedical Innovation Health and Nutrition
Original Assignee
Mirror Co ltd
National Institutes of Biomedical Innovation Health and Nutrition
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirror Co ltd, National Institutes of Biomedical Innovation Health and Nutrition filed Critical Mirror Co ltd
Publication of CN113631923A publication Critical patent/CN113631923A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202080022905.2A 2019-03-22 2020-03-23 辅助肾病况的评价的方法、肾病况的评价系统及肾病况的评价程序 Pending CN113631923A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019055744 2019-03-22
JP2019-055744 2019-03-22
JP2019057357 2019-03-25
JP2019-057357 2019-03-25
PCT/JP2020/012807 WO2020196437A1 (ja) 2019-03-22 2020-03-23 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム

Publications (1)

Publication Number Publication Date
CN113631923A true CN113631923A (zh) 2021-11-09

Family

ID=72611044

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080022905.2A Pending CN113631923A (zh) 2019-03-22 2020-03-23 辅助肾病况的评价的方法、肾病况的评价系统及肾病况的评价程序

Country Status (4)

Country Link
US (1) US20220170945A1 (https=)
JP (2) JP7733909B2 (https=)
CN (1) CN113631923A (https=)
WO (1) WO2020196437A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120260975A (zh) * 2025-06-05 2025-07-04 山东中医药大学附属医院 一种肾病病理分析系统

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021132658A1 (ja) * 2019-12-27 2021-07-01 Kagami株式会社 腎機能を推定する方法及びシステム
JP7113121B1 (ja) * 2021-06-28 2022-08-04 貞夫 吉田 骨格筋量推定システム、骨格筋量推定装置及びプログラム
WO2025211123A1 (ja) * 2024-04-01 2025-10-09 花王株式会社 尿検査システム及びプログラム

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113631927A (zh) * 2019-03-22 2021-11-09 镜株式会社 辅助肾病况的评价的方法、肾病况的评价系统及肾病况的评价程序

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3761034A3 (en) * 2011-01-26 2021-02-17 University of Pittsburgh - Of the Commonwealth System of Higher Education Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
CN110133296B (zh) * 2012-03-18 2022-03-25 镜株式会社 疾病样品分析装置、分析系统及分析方法
US10393749B2 (en) * 2013-12-11 2019-08-27 Shiseido Company, Ltd. Marker for early diagnosis of kidney failure
JP6609282B2 (ja) * 2016-05-17 2019-11-20 国立大学法人大阪大学 糖尿病を判定するための血液試料の分析方法及びシステム
AU2017266330A1 (en) * 2016-05-17 2018-12-06 Osaka University Kidney disease prognosis prediction method and system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113631927A (zh) * 2019-03-22 2021-11-09 镜株式会社 辅助肾病况的评价的方法、肾病况的评价系统及肾病况的评价程序

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120260975A (zh) * 2025-06-05 2025-07-04 山东中医药大学附属医院 一种肾病病理分析系统

Also Published As

Publication number Publication date
JP7733909B2 (ja) 2025-09-04
US20220170945A1 (en) 2022-06-02
JPWO2020196437A1 (https=) 2020-10-01
WO2020196437A1 (ja) 2020-10-01
JP2025075096A (ja) 2025-05-14

Similar Documents

Publication Publication Date Title
JP2025075096A (ja) 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム
JP2025143471A (ja) 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム
US10852308B2 (en) Disease-state biomarker for renal disease
JP6993654B2 (ja) 腎機能を推定する方法及びシステム
JP7471581B2 (ja) 腎臓病の病態バイオマーカー
US20210373030A1 (en) Marker for determing critical stage kidney disease
WO2020080482A1 (ja) 血液中のシスタチンｃ量に基づく腎機能検査結果の妥当性を検定する方法
WO2020080494A1 (ja) クリティカル期の腎障害を判定するためのマーカー
WO2020080491A1 (ja) 血液中のクレアチニン量に基づく腎機能検査結果の妥当性を検定する方法
US12360117B2 (en) Method for determining glomerular filtration ability

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20211109